Cargando…
The role of everolimus in treatment of cardiac allograft vasculopathy
Autor principal: | Watanabe, Tetsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese College of Cardiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275357/ https://www.ncbi.nlm.nih.gov/pubmed/30533159 http://dx.doi.org/10.1016/j.jccase.2013.03.008 |
Ejemplares similares
-
Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021) -
Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020) -
Multiparametric Cardiac Magnetic Resonance Imaging for Diagnosing Cardiac Allograft Vasculopathy
por: Lee, Ji Won
Publicado: (2022) -
Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015) -
T(mem) time: Memory T-Cells in Cardiac Allograft Vasculopathy: Editorial to: “Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody” by Hao Wang et al.
por: Seidman, Michael A.
Publicado: (2014)